We are now carrying out clinical research, genetical research and pathological research of neuronal intranuclear inclusion disease (NIID) at Suzuka National Hospital.
NIID is a neurodegenerative disease whose main symptoms are forgetfulness (dementia) and muscular weakness of the limbs, and /or ataxia. The first case of NIID was reported in 1968, and since then NIID cases has been diagnosed and reported with same histopathological features of ubiquitin-positive intranuclear inclusion from autopsy samples (Figure 1). In 2011, we discovered and reported that skin biopsy is useful for the diagnosis of NIID (Figure 2), afterwards the number of NIID case reports has dramatically increased.
In particular, many cases were diagnosed as NIID that initial symptom was forgetfulness occurs in the elderly, and showing abnormal white matter high intensity signals in head MRI T2 imaging and abnormal high intensity signals along the corticomedullary junction in diffusion weighted imaging (DWI) (Figure 3). Such MRI T2 findings look very much alike the MRI finding of chronic ischemic change, many NIID cases may have been overlooked till now.
Suzuka National Hospital is the unique institute that has plenty of experience of NIID diagnosis by skin biopsy samples.
Please contact us if you find a suspected case of NIID.
We are now studying many cases of NIID at Suzuka National Hospital, and promoting clinical research of NIID and genetical research, especially the relationship of clinical symptoms between genetical repeat expansion, and developing radial remedy of NIID (e-mail: niiddiagnosis@gmail.com).